These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Prospects for the use of NK cells in immunotherapy of human cancer.
    Author: Ljunggren HG, Malmberg KJ.
    Journal: Nat Rev Immunol; 2007 May; 7(5):329-39. PubMed ID: 17438573.
    Abstract:
    Current insights into the molecular specificities that regulate natural killer (NK)-cell function suggest that it might be possible to design NK-cell-based immunotherapeutic strategies against human cancer. Here, we describe evidence for NK-cell targeting of human tumours and address crucial questions that, in our opinion, require consideration for the development of successful NK-cell-based therapies. Appropriately used, we predict that NK cells will have a role, both directly and in combination with other treatment modalities, in future treatment of cancer.
    [Abstract] [Full Text] [Related] [New Search]